PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN
Flaifel, Abdallah, Xie, Wanling, Braun, David A., Ficial, Miriam, Bakouny, Ziad, Nassar, Amin H., Jennings, Rebecca B., Escudier, Bernard, George, Daniel J., Motzer, Robert J., Morris, Michael J., PowVolume:
25
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-1135
Date:
October, 2019
File:
PDF, 354 KB
english, 2019